Active Ulcerative Colitis clinical trials

Explore recruiting active ulcerative colitis clinical trials.

Recruiting active ulcerative colitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Active Ulcerative Colitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Fecal microbiota transplantation in patients receiving infliximab and vedolizumab for ulcerative colitis: A randomized controlled trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Confirm Efficacy and Safety of MH002 and to Assess the Effect of Dose in Patients With Mild-to-Moderate Ulcerative Colitis Insufficiently Controlled With 5-Aminosalicylic Acid

Czechia, Poland, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Austria, Poland, Croatia, Netherlands, Germany, Greece +12 more

Therapeutic exploratory (Phase II) EU CTIS Study details

C5041012 (APD334-303) - An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis

Poland, Portugal, Hungary, Czechia, Romania, Slovakia +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A follow-up Phase II open-label study to evaluate the long-term safety and efficacy profile of ABX464 given at 25 mg once daily in subjects with Moderate to Severe Active Ulcerative Colitis

Slovakia, Spain, Slovenia, Belgium, France, Hungary +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Induction Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects With Moderately to Severely Active Ulcerative Colitis

Italy, Hungary, Belgium, Denmark, Romania, Slovakia +7 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Active Ulcerative Colitis trials by city

Active Ulcerative Colitis in Toronto Active Ulcerative Colitis in Vancouver Active Ulcerative Colitis in Montreal Active Ulcerative Colitis in Calgary Active Ulcerative Colitis in Edmonton Active Ulcerative Colitis in Ottawa Active Ulcerative Colitis in Winnipeg Active Ulcerative Colitis in Quebec City Active Ulcerative Colitis in Hamilton Active Ulcerative Colitis in Kitchener Active Ulcerative Colitis in London Active Ulcerative Colitis in Halifax Active Ulcerative Colitis in New York Active Ulcerative Colitis in Los Angeles Active Ulcerative Colitis in Chicago Active Ulcerative Colitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease